Aspira Women's Health Inc.
AWHL
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -13.09M | -14.80M | -15.95M | -14.74M | -16.69M |
| Total Depreciation and Amortization | 92.00K | 115.00K | 132.00K | 158.00K | 199.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 192.00K | -835.00K | 560.00K | 83.00K | 372.00K |
| Change in Net Operating Assets | 697.00K | 973.00K | 319.00K | -119.00K | 225.00K |
| Cash from Operations | -12.11M | -14.54M | -14.94M | -14.62M | -15.89M |
| Capital Expenditure | -37.00K | -49.00K | -47.00K | -36.00K | -24.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -37.00K | -49.00K | -47.00K | -36.00K | -24.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -93.00K | -35.00K | 2.00K | -63.00K | -148.00K |
| Issuance of Common Stock | 10.28M | 10.37M | 12.78M | 11.90M | 6.10M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 879.00K | 1.03M | -1.33M | -1.29M | -731.00K |
| Cash from Financing | 11.06M | 11.37M | 11.45M | 10.54M | 5.22M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.09M | -3.22M | -3.54M | -4.12M | -10.70M |